Medicare Enrolled
Dr. Craig Shalmi, M.D.
Pain Medicine · Babylon, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Shalmi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shalmi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Shalmi
Dr. Craig Shalmi is a pain medicine specialist in Babylon, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Shalmi performed 3,962 Medicare services across 1,848 unique beneficiaries.
Between the years covered by Open Payments, Dr. Shalmi received a total of $8,127 from 44 pharmaceutical and/or device companies across 254 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Shalmi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 13% volume in NY
$8,127 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,962
Medicare services
Top 13% in NY for pain medicine
1,848
Unique beneficiaries
$80
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~209 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
918 | $1 | $10 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
686 | $109 | $450 |
| Betamethasone steroid injection An injection containing a combination of betamethasone acetate and betamethasone sodium phosphate. |
398 | $5 | $30 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
249 | $84 | $320 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
233 | $68 | $271 |
| Fluoroscopic guidance for needle placement Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure. |
198 | $111 | $430 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
163 | $283 | $1,278 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
144 | $149 | $580 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
133 | $9 | $40 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
96 | $235 | $973 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
89 | $109 | $410 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
88 | $54 | $200 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
75 | $218 | $1,083 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
74 | $116 | $549 |
| Trigger point injection, 1-2 muscles A procedure involving the injection of medication into one or two specific muscles to treat trigger points. |
69 | $48 | $190 |
| Drug test with direct observation A drug screening test performed under direct observation to ensure the sample is provided correctly. This method is used to verify the integrity of the specimen collection process. |
64 | $12 | $40 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement. |
40 | $203 | $923 |
| Facet joint injection, second level, with imaging An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement. |
38 | $106 | $442 |
| Spinal injection with imaging guidance A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location. |
34 | $237 | $990 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
34 | $400 | $1,540 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
33 | $223 | $650 |
| Injection, methylprednisolone acetate, 40 mg | 30 | $5 | $20 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
28 | $90 | $390 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
20 | $0 | $10 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
17 | $53 | $220 |
| Contrast dye for imaging, lower concentration | 11 | $0 | $10 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$8,127
Total received (2018-2024)
Avg $1,161/year across 7 years
Top 17% in NY for pain medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
44
Companies
254
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,127 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$913
2023
$963
2022
$599
2021
$498
2020
$544
2019
$3,674
2018
$936
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$263
ABBVIE INC.
$151
SCILEX PHARMACEUTICALS INC.
$131
Abbott Laboratories
$75
Curonix LLC
$71
Medtronic, Inc.
$39
PFIZER INC.
$35
SI-BONE, INC.
$32
DePuy Synthes Sales Inc.
$25
PAINTEQ LLC
$24
Azurity Pharmaceuticals, Inc.
$21
IDORSIA PHARMACEUTICALS US INC
$16
Fidia Pharma USA Inc.
$16
Collegium Pharmaceutical, Inc.
$15
Top 3 companies account for 59.7% of 2024 payments
All-time payments by company (2018-2024) ›
Abbott Laboratories
$1,344
Boston Scientific Corporation
$1,161
Vertos Medical, Inc.
$1,007
Nevro Corp.
$921
BOSTON SCIENTIFIC CORPORATION
$647
Medtronic USA, Inc.
$552
Medtronic, Inc.
$423
Daiichi Sankyo Inc.
$169
SCILEX PHARMACEUTICALS INC.
$155
ABBVIE INC.
$151
DePuy Synthes Sales Inc.
$131
Horizon Therapeutics plc
$112
Allergan Inc.
$104
AbbVie Inc.
$102
Stimwave Technologies Incorporated
$92
SI-BONE, Inc.
$90
Almatica Pharma LLC
$86
Curonix LLC
$71
Arbor Pharmaceuticals, Inc.
$63
Horizon Pharma plc
$63
Flexion Therapeutics, Inc.
$60
Collegium Pharmaceutical, Inc.
$57
PFIZER INC.
$50
Purdue Pharma L.P.
$42
Aziyo Biologics, Inc.
$41
Scilex Pharmaceuticals Inc.
$41
Nalu Medical, Inc.
$32
SI-BONE, INC.
$32
Bioventus LLC
$31
Sentynl Therapeutics, Inc.
$28
AstraZeneca Pharmaceuticals LP
$28
PAINTEQ LLC
$24
IBSA Pharma Inc.
$23
Shionogi Inc
$22
Azurity Pharmaceuticals, Inc.
$21
Pacira Pharmaceuticals Incorporated
$21
ARBOR PHARMACEUTICALS, INC.
$20
FIDIA PHARMA USA INC.
$17
ASSERTIO THERAPEUTICS, Inc.
$17
Allergan, Inc.
$17
IDORSIA PHARMACEUTICALS US INC
$16
Fidia Pharma USA Inc.
$16
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$15
Kaleo, Inc.
$12
Top 3 companies account for 43.2% of all-time payments
Associated products mentioned in payments ›
AUTOFILL · AXIUM · BOTOX · Belbuca · CFNS StimQ Peripheral Nerve StimulatorSystem · Cambia · DUEXIS · Durolane · ECM Patch · Evzio · GENERAL PAIN MANAGEMENT · GENERAL THERAPIES · GENERAL - PAIN MANAGEMENT · GENERAL PAIN MANAGEMENT · GRALISE · General - Pain Management · HORIZANT · HYMOVIS · Horizant · Hymovis · INTELLIS · INTELLIS ADAPTIVESTIM · Iovera · LICART · LOREEV XR · LYRICA · Levorphanol · MONOVISC · MOVANTIK · Morphabond ER · NURTEC ODT · Nalu Neurostimulation System · Neuromodulation Dspsbls and Accs · ORTHOVISC · OXYCONTIN · Omnia · PAINTEQ · PENNSAID · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PROCLAIM · Pouch · Proclaim DRG IPG · Proclaim Family of SCS IPGs · Prodigy Family of SCS IPGs · QULIPTA · QUVIVIQ · RELISTOR · RESTORE · SCS IPGs · SPECTRA WAVEWRITER · SPECTRA WAVEWRITER (REFURBISHED) · SYMPROIC · Senza · Senza Spinal Cord Stimulation System · Symproic · UBRELVY · WaveWriter Alpha Prime 16 · XTAMPZA · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zilretta · iFuse Implant · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pain medicines within 10 mi
49
Per 100K population
3.2
County median income
$128,329
Nearest hospital
BRUNSWICK HOSPITAL CENTER, INC.
3.6 mi
3.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Shalmi is a clinical cardiology specialist, with above-average Medicare volume (top 13% in NY), with low-engagement industry engagement in the top 17% of NY peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Shalmi experienced with steroid injection (triamcinolone)?
Based on Medicare claims data, Dr. Shalmi performed 918 steroid injection (triamcinolone) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shalmi receive payments from pharmaceutical companies?
Yes. Dr. Shalmi received a total of $8,127 from 44 companies across 254 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shalmi's costs compare to other pain medicines in Babylon?
Dr. Shalmi's average Medicare payment per service is $80. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shalmi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Pain Medicines in Babylon
Browse pain medicines in Babylon ranked by procedure volume and transparency data.
Highest volume
Top Pain Medicines in NY
Pain medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pain Medicines in NY
Which NY pain medicines receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Vertos Medical, Inc. Payments to Doctors
See all physicians who received payments from Vertos Medical, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology